摘要:
Chemotherapeutic antineoplastic method comprising administration of an effective amount of an antineoplastic agent in conjunction with an effective amount of a β-1,3 glucan.
摘要:
Therapeutical method comprising administration to a patient of an effective amount of especially soluble laminarin for the treatment of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and for the treatment of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals.
摘要:
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal antibody is administered with either β-(1,3)-glucan like laminarin or a oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to patients suffering from cancer are described.
摘要:
A therapeutical method comprising administration of a composition comprising an amount of oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to a human being or to a warm-blood animal suffering from a disease selected from the group consisting in a tumor, a cancer, a viral disease, a bacterial disease, a fungal disease, a disease of the immune system, an auto-immune disease or a disease related to a deficiency of immunostimulation, wherein the amount of oligo-β-(1,3)-glucan is effective to treat the disease.
摘要:
Chemotherapeutic antineoplastic method comprising administration of an effective amount of an antineoplastic agent in conjunction with an effective amount of a β-1,3 glucan.
摘要:
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal antibody is administered with either β-(1,3)-glucan like laminarin or a oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to patients suffering from cancer are described.
摘要:
The invention relates to an automated method for positioning eggs on a tray that comprises the automated detection of the presence/absence of eggs in the cells of a tray, and the picking-up of eggs from a supply and the placement thereof in the empty cells of a tray. The invention also relates to a system or positioning eggs on a stabilizing tray, the tray including evenly distributed cells in which the eggs are placed, one or more cells being likely not to contain eggs, this information being stored in an information processing unit, wherein said system includes a means in the form of a robot having an egg pick-up head that are driven by the information processing unit in order to pick up eggs from a supply tray and to place them in the empty cells of the stabilizing tray.
摘要:
The subject matter of the present invention is a composition for inhibiting urease and nitrification, which may be in liquid or solid form and which comprises at least one compound for inhibiting urease, of phosphoramide type, combined with an essential oil of Allium preferably originating from Allium sativum. This composition may be used in combination with a urea-based fertilizer for the manufacture of fertilizing compositions.
摘要:
The present invention concerns an injection method for injecting a substance into eggs, and an injection head for implementing said method. The method generally includes piercing the shell and at least the shell membrane of an egg by moving a needle, and then injecting the treatment substance via said needle, said piercing step comprising a first movement of the needle to pierce the shell with a first penetration force and then a second movement of the needle to pierce at least the shell membrane with a second penetration force lower than the first penetration force.
摘要:
This invention relates to the use of a sulphated or phosphated polysaccharide for the preparation of a medicine for treatments against retroviruses, more particularly against lentiviruses and oncoviruses, and particularly against HIV, including strains of these retroviruses that are resistant to known anti-retroviral agents; this medicine acts on the replication cycle of said retroviruses by inhibition of their RT.